GlassScriptPhysician profile
Tansel Turgut
NPI 1104829886
$8,201.43
in general payments reported to CMS, 2019-2025
33 companies · $1,817 in 2025
The $1,817 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,091 · 2020: $449 · 2021: $286 · 2022: $874 · 2023: $744 · 2024: $2,939 · 2025: $1,817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,166 · Travel and Lodging: $2,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,166.01 |
| Travel and Lodging | $2,334.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,122.12 | 2020-2025 | Indigo System |
| Novartis Pharmaceuticals Corporation | $970.62 | 2019-2025 | |
| Shockwave Medical, INC | $821.40 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $507.58 | 2019-2023 | Repatha |
| Boston Scientific Corporation | $479.13 | 2019-2025 | S-Icd System Magnet, Cds - Mct/Cem Monitoring |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $305.43 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $289.66 | 2019-2023 | Xarelto |
| Abiomed | $236.53 | 2023-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.01 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $135.05 | 2019-2022 | |
| Medtronic, INC. | $128.55 | 2024-2025 | Corevalve Evolut R, Micra |
| Cardiovascular Systems INC. | $113.98 | 2022-2023 | Diamondback Coronary |
| Abbott Laboratories | $110.83 | 2023-2025 | Cardiomems, Amplatzer Talisman |
| Esperion Therapeutics, INC. | $106.47 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $91.50 | 2024-2025 | Verquvo |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $88.44 | 2022-2025 | |
| Actelion Pharmaceuticals US, INC. | $68.51 | 2019-2020 | |
| Pfizer INC. | $57.64 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $46.66 | 2019-2020 | |
| Astellas Pharma US INC | $43.41 | 2019-2021 | |
| Philips North America LLC | $42.85 | 2022 | |
| Angiodynamics, INC. | $34.76 | 2019-2023 | Auryon Laser System 100-120 Vac |
| Chiesi USA, INC. | $28.89 | 2023 | Kengreal, Cleviprex |
| Medtronic Vascular, INC. | $28.82 | 2019 | |
| Getinge USA Sales, LLC | $27.88 | 2022-2023 | Cardiosave Hybrid, Type B Plug |
| Regeneron Healthcare Solutions, INC. | $26.38 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.87 | 2022 | |
| Cordis US Corp. | $19.48 | 2023 | Mynxgrip |
| Kestra Medical Technology Services, INC. | $18.21 | 2025 | Assure Wcd |
| Lantheus Medical Imaging, INC. | $17.73 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $17.03 | 2023 | Inpefa |
| Aegerion Pharmaceuticals, INC. | $16.33 | 2019 | |
| Terumo Medical Corporation | $14.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tansel Turgut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.